| Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma (NCT02449109) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men (NCT02107118) | Baylor College of Medicine | 2015-05-01 |
| Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme (NCT01317212) | North Bristol NHS Trust | 2015-05-01 |
| Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers (NCT02442310) | ApoPharma | 2015-05-01 |
| Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age. (NCT02459262) | Minervax ApS | 2015-05-01 |
| Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery (NCT02462681) | Assiut University | 2015-05-01 |
| Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function (NCT02441829) | Gilead Sciences | 2015-05-01 |
| APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee (NCT02210468) | Cytonics Corporation | 2015-05-01 |
| Cord Blood Infusion for Ischemic Stroke (NCT02397018) | Joanne Kurtzberg, MD | 2015-05-01 |
| Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography (NCT02437539) | Rigshospitalet, Denmark | 2015-05-01 |
| A Study of LY3022855 In Participants With Breast or Prostate Cancer (NCT02265536) | Eli Lilly and Company | 2015-05-01 |
| Gene Therapy for Transfusion Dependent Beta-thalassemia (NCT02453477) | IRCCS San Raffaele | 2015-05-01 |
| Study of the CD40 Agonistic Monoclonal Antibody APX005M (NCT02482168) | Apexigen America, Inc. | 2015-05-01 |
| Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Acute Lung Injury (NCT02444455) | Affiliated Hospital to Academy of Military Medical Sciences | 2015-05-01 |
| Iron Stores and Skeletal Muscle Metabolism in Chronic Heart Failure (NCT02737995) | NYU Langone Health | 2015-05-01 |
| A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects (NCT02460393) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2015-05-01 |
| Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin (NCT02414269) | Memorial Sloan Kettering Cancer Center | 2015-05-01 |
| A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS (NCT02473627) | Daiichi Sankyo | 2015-05-01 |
| Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects (NCT02438696) | Boehringer Ingelheim | 2015-05-01 |
| A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China (NCT02269007) | Jiangsu Province Centers for Disease Control and Prevention | 2015-05-01 |
| Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury (NCT02444858) | Affiliated Hospital to Academy of Military Medical Sciences | 2015-05-01 |
| Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection (NCT03119025) | Russian Academy of Medical Sciences | 2015-05-01 |
| Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients (NCT02456844) | Bristol-Myers Squibb | 2015-05-01 |
| University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial (NCT02508259) | University of California, San Diego | 2015-05-01 |
| Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers (NCT02464670) | Inovio Pharmaceuticals | 2015-05-01 |
| Young Plasma Transfusions for Progressive Supranuclear Palsy (NCT02460731) | University of California, San Francisco | 2015-05-01 |
| Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration (NCT02302989) | Leonard Feiner, MD, PhD | 2015-05-01 |
| Single Ascending Dose Study of PRX003 in Healthy Subjects (NCT02458677) | Prothena Biosciences Limited | 2015-05-01 |
| Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon (NCT02440841) | Vantia Ltd | 2015-05-01 |
| Radiotherapy & Combi in Metastatic Melanoma (NCT02392871) | Melanoma and Skin Cancer Trials Limited | 2015-05-01 |
| Topical Lidocaine After Arthroscopy on Knee (NCT02460627) | Northern Orthopaedic Division, Denmark | 2015-05-01 |
| A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects (NCT02447315) | Astellas Pharma Europe B.V. | 2015-05-01 |
| Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis (NCT02442037) | Affiliated Hospital to Academy of Military Medical Sciences | 2015-05-01 |
| Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke (NCT02433509) | China Medical University Hospital | 2015-05-01 |
| Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis (NCT02116634) | Alzahra Hospital, Iran | 2015-05-01 |
| First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers (NCT02448264) | BioCryst Pharmaceuticals | 2015-05-01 |
| A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab (NCT02422199) | Jiangsu HengRui Medicine Co., Ltd. | 2015-05-01 |
| A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects (NCT02440633) | Otsuka Pharmaceutical Co., Ltd. | 2015-05-01 |
| A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects (NCT02439359) | ContraFect | 2015-05-01 |
| Study of DSP-7888 in Patients With Myelodysplastic Syndrome (NCT02436252) | Sumitomo Pharma Co., Ltd. | 2015-05-01 |
| Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China (NCT02456610) | Affiliated Hospital to Academy of Military Medical Sciences | 2015-05-01 |
| Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma (NCT02449122) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug (NCT01702675) | Ache Laboratorios Farmaceuticos S.A. | 2015-05-01 |
| Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI (NCT02437253) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2015-05-01 |
| SUBLIVAC FIX Mite Mixture Dose Tolerability Study (NCT02345278) | HAL Allergy | 2015-05-01 |
| A Dose-escalating Clinical Trial With KH176 (NCT02544217) | Khondrion BV | 2015-05-01 |
| PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer (NCT02483884) | Lantheus Biosciences Ltd. | 2015-05-01 |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer (NCT02447263) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants (NCT02406261) | AstraZeneca | 2015-04-30 |
| Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects (NCT02551497) | Biogen | 2015-04-30 |
| Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. (NCT02417831) | Boehringer Ingelheim | 2015-04-30 |
| Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment (NCT02447406) | Samsung Medical Center | 2015-04-30 |
| A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT02412371) | AbbVie | 2015-04-30 |
| Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma (NCT02335983) | Amgen | 2015-04-30 |
| Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF) (NCT02806882) | Centre Hospitalier Universitaire Dijon | 2015-04-29 |
| Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... (NCT02390752) | National Cancer Institute (NCI) | 2015-04-29 |
| Trial of Afatinib in Pediatric Tumours (NCT02372006) | Boehringer Ingelheim | 2015-04-29 |
| A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma (NCT02343536) | Celgene | 2015-04-29 |
| Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002) (NCT02392494) | Merck Sharp & Dohme LLC | 2015-04-28 |
| Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441 (NCT02479204) | Viatris Innovation GmbH | 2015-04-28 |
| Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients (NCT02987413) | Hospital e Maternidade Dr. Christóvão da Gama | 2015-04-28 |
| A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients (NCT02367456) | Pfizer | 2015-04-28 |
| A Crossover Study to Evaluate Relative Bioavailability of Simeprevir Age-appropriate Oral Formulation Candidates Compared With 150-milligram (mg) Oral Capsule in Healthy Adult Participants (NCT02385071) | Janssen Sciences Ireland UC | 2015-04-28 |
| Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity (NCT02390531) | Jaeb Center for Health Research | 2015-04-28 |
| Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults (NCT02377401) | GlaxoSmithKline | 2015-04-28 |
| A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours (NCT03427073) | Almac Discovery | 2015-04-27 |
| HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer (NCT02464137) | University of Texas Southwestern Medical Center | 2015-04-27 |
| Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors (NCT02429466) | Nasser Hanna | 2015-04-27 |
| Phase I/II Study of PDR001 in Patients With Advanced Malignancies (NCT02404441) | Novartis Pharmaceuticals | 2015-04-27 |
| Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal Neuropathy (NCT02362438) | National Institute of Neurological Disorders and Stroke (NINDS) | 2015-04-24 |
| Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation (NCT02531906) | Roswell Park Cancer Institute | 2015-04-24 |
| A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors (NCT02410512) | Genentech, Inc. | 2015-04-24 |
| Dose-Seeking Study of MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment (NCT02350868) | Taipei Medical University | 2015-04-24 |
| Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 (NCT02315066) | Pfizer | 2015-04-23 |
| Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT02429375) | Memorial Sloan Kettering Cancer Center | 2015-04-22 |
| Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects. (NCT04037657) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2015-04-22 |
| A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects (NCT02386436) | GlaxoSmithKline | 2015-04-21 |
| Oral Guanabenz for Multiple Sclerosis (NCT02423083) | National Institute of Neurological Disorders and Stroke (NINDS) | 2015-04-21 |
| A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function (NCT02372084) | Novartis Pharmaceuticals | 2015-04-21 |
| Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02316964) | Sumithira Vasu | 2015-04-21 |
| Safety Study of AMG 228 to Treat Solid Tumors (NCT02437916) | Amgen | 2015-04-21 |
| Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL (NCT02342665) | Bayer | 2015-04-21 |
| Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma (NCT02348216) | Kite, A Gilead Company | 2015-04-21 |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants (NCT02440035) | Crucell Holland BV | 2015-04-21 |
| A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC (NCT02309892) | Helix BioPharma Corporation | 2015-04-20 |
| Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma (NCT02269085) | M.D. Anderson Cancer Center | 2015-04-20 |
| Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer (NCT02390427) | Otto Metzger, MD | 2015-04-20 |
| A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer (NCT02424617) | BerGenBio ASA | 2015-04-19 |
| Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy (NCT02390713) | Assistance Publique - Hôpitaux de Paris | 2015-04-18 |
| Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function (NCT02400307) | Gilead Sciences | 2015-04-17 |
| QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab (NCT02384954) | Altor BioScience | 2015-04-17 |
| A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba (NCT02510768) | Elastagen Pty Ltd | 2015-04-16 |
| Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma (NCT02311920) | National Cancer Institute (NCI) | 2015-04-16 |
| Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML (NCT02311998) | M.D. Anderson Cancer Center | 2015-04-16 |
| Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833 (NCT02437227) | Royal Marsden NHS Foundation Trust | 2015-04-15 |
| Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers (NCT02392468) | Boehringer Ingelheim | 2015-04-15 |
| Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab (NCT02330562) | Celgene | 2015-04-15 |
| PCA062 in pCAD-positive Tumors. (NCT02375958) | Novartis Pharmaceuticals | 2015-04-15 |
| A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer (NCT02439450) | Heat Biologics | 2015-04-15 |
| AADC Gene Therapy for Parkinson's Disease (NCT02418598) | Jichi Medical University | 2015-04-14 |